Information for Our Community

Whether you are part of our community or are interested in joining us, we welcome you to WashU Medicine.

close  


Visit the News Hub

Obituary: Katherine Parker Ponder, professor emerita of hematology, 69

Physician-scientist helped improve treatment for patients with lysosomal storage diseases

August 18, 2026

Katherine Parker Ponder, MD, professor emerita of medicine and of biochemistry and molecular biophysics at Washington University School of Medicine in St. Louis, died July 18, 2026, of breast cancer. She was 69.

A highly accomplished physician-scientist, Ponder’s career spanned decades at WashU Medicine. She made significant advances in techniques to treat lysosomal storage diseases — rare, incurable, inherited metabolic diseases that collectively affect a significant swath of the world’s population.

Ponder was noted for improving treatments via gene therapy for such diseases. She was key in helping to develop more-effective approaches by using retroviral vectors, a process by which RNA, a translator of genetic code, is used to insert therapeutic genes into cells.

“Dr. Ponder was a very successful, creative and incredibly dedicated physician-scientist who proved to be a wonderful mentor and a valued, longtime member of the hematology faculty,” said Victoria J. Fraser, MD, the Adolphus Busch Professor of Medicine and head of the John T. Milliken Department of Medicine. “She was amazingly courageous and resilient, and continued working on her research throughout most of her long and difficult battle with breast cancer. She will be deeply missed.”

Earlier in her career, Ponder studied hemophilia, a disease that prevents blood from clotting normally. She hypothesized that if a healthy copy of the missing gene could be placed into liver cells, the liver could make the needed clotting protein that could help stop dangerous bleeding.

Ponder applied the same idea to mucopolysaccharidoses, a group of inherited diseases in which the body cannot break down certain complex sugars. These substances collect inside cells and can cause damage to the brain, heart, bones and other organs. Her studies offered hope that similar gene-based treatments might one day help patients with rare diseases.

Ponder earned a bachelor’s degree in biology from Stanford University and a medical degree from WashU Medicine.

After completing residency training in Texas and Connecticut, she joined the faculty of WashU Medicine in 1990. She was appointed professor emerita in 2014.

Throughout her career, Ponder received numerous awards and participated in several professional societies and organizations. In 2016 she was honored with the Sonia Skarlatos Public Service Award from the American Society of Gene and Cell Therapy for her dedication to advancing the field.

Ponder had strong familial ties to WashU. Her parents — Mary Langston Parker, MD, and Charles Ward Parker, MD — were physicians, researchers and instructors at WashU Medicine. Ponder’s four siblings also graduated with WashU degrees.

She is survived by her husband, Jay William Ponder, PhD, a professor of chemistry, of biochemistry and molecular biophysics, and of biomedical engineering at WashU; her children, Kaitlin and Tyler (Anna Huang); and her siblings, Charlie, Christy and Sandy Parker Bigg.

A memorial service will be held at 1 p.m. Saturday, Sept. 19, at First Congregational Church, 10 W. Lockwood Avenue, Webster Groves, Mo.

In lieu of flowers, the family requested tribute gifts are made to the Katherine Parker Ponder Memorial Endowment. The fund will be used to support trainees and early career faculty in the Division of Hematology, including research, education, travel to conferences or travel for other reasons, speaking engagements, and other uses that would support trainees and early career faculty as they progress in their careers. Gifts to this fund will honor Katherine “Kathy” Parker Ponder, MD, recognizing her distinguished career as a physician-scientist, her deep commitment to advancing patient care and scientific discovery, and the many lives she touched through her generosity, mentorship, and vibrant spirit.

Gifts can be made online at giving.wustl.edu/Ponder or by mailed check to “Washington University” and including “Katherine Parker Ponder Memorial Endowment” in the memo line or included note. Checks can be mailed to “MSC 1082-414-2555, 7425 Forsyth Blvd., Clayton, MO 63105.”

For more information on Ponder’s life, please visit the family’s obituary.

About WashU Medicine

WashU Medicine is a global leader in academic medicine, including biomedical research, patient care and educational programs with 3,100 faculty. Its National Institutes of Health (NIH) research funding portfolio is the second largest among U.S. medical schools and has grown 78% since 2016. Together with institutional investment, WashU Medicine commits over $1.6 billion annually to basic and clinical research innovation and training. Its faculty practice is consistently among the top five in the country, with more than 2,550 faculty physicians practicing at 200 locations. WashU Medicine physicians exclusively staff Barnes-Jewish and St. Louis Children’s hospitals — the academic hospitals of BJC HealthCare — and Siteman Cancer Center, a partnership between BJC HealthCare and WashU Medicine and the only National Cancer Institute-designated comprehensive cancer center in Missouri and southern Illinois. WashU Medicine physicians also treat patients at BJC’s community hospitals in our region. With a storied history in MD/PhD training, WashU Medicine recently dedicated $100 million to scholarships and curriculum renewal for its medical students, and is home to top-notch training programs in every medical subspecialty as well as physical therapy, occupational therapy, and audiology and communications sciences.